Susan O'Brien
13PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Apr 13, 2018
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.Hagop M Kantarjian, Courtney D DiNardo, Graciela M Nogueras-Gonzalez
|Jan 31, 2018
Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE.Elias J Jabbour, Daniel J DeAngelo, Matthias Stelljes
|Dec 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase.Koji Sasaki, Hagop Kantarjian, Susan O'Brien
|Jul 26, 2017
Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.Preetesh Jain, Hagop M Kantarjian, Ahmad Ghorab
|Jul 15, 2017
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.Elias Jabbour, Nicholas J Short, Farhad Ravandi
|Jun 14, 2017
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.Rashmi Kanagal-Shamanna, Preetesh Jain, Koichi Takahashi
Pageof 3
Frequent Collaborators
4 joint publications
Koji Sasaki
4 joint publications
Naval G Daver
4 joint publications
Tapan M Kadia
3 joint publications
Hagop M Kantarjian
3 joint publications
Elias Jabbour
3 joint publications
Preetesh Jain
2 joint publications
Nicholas J Short
2 joint publications
Rashmi Kanagal-Shamanna
1 joint publications
Paul B Koller
1 joint publications
Courtney D DiNardo
